Search research articles
Contact Us
Filters
Showing results (101-110 of 265) with videos related to
Page
of 27
Sort By:
Cancer Management and Research
|
December 29, 2010
Validation of the cell cycle G(2) delay assay in assessing ionizing radiation sensitivity and breast cancer risk
Jeff W Hill, Kristina Tansavatdi, Kristin L Lockett, et al.
Cancer
|
April 11, 2007
Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate
Thomas N Eade, Tahseen Al-Saleem, Eric M Horwitz, et al.
Cancer
|
October 31, 2007
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer
Matthew C Abramowitz, Tiaynu Li, Mark K Buyyounouski, et al.
Pharmaceutics
|
July 29, 2023
Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody-Gaussia Luciferase Fusion Protein
Jessica Hersh, Yu-Ping Yang, Evan Roberts, et al.
Journal of the American Animal Hospital Association
|
June 30, 2026
Intra-alveolar Adhesive Biomaterial Preserves Ridge Height After Tooth Extraction in Dogs
Christopher Snyder, Robert Baratt, Susan Crowder, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 25, 2010
Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?
Deborah A Kuban, Lawrence B Levy, M Rex Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 8, 2021
Prostate Cancer Targeted X-Ray Fluorescence Imaging via Gold Nanoparticles Functionalized With Prostate-Specific Membrane Antigen (PSMA)
Daiki Hara, Wensi Tao, Tulasigeri M Totiger, et al.
Journal of Applied Clinical Medical Physics
|
August 23, 2007
Comparing computed tomography localization with daily ultrasound during image-guided radiation therapy for the treatment of prostate cancer: a prospective evaluation
Steven J Feigenberg, Kamen Paskalev, Shawn McNeeley, et al.
The Prostate
|
January 16, 2008
Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo
Zhaomei Mu, Paul Hachem, Harvey Hensley, et al.
Cancer
|
March 26, 2003
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x
Alan Pollack, Didier Cowen, Patricia Troncoso, et al.
Page
of 27
Search research articles
Search
Showing results (101-110 of 265) with videos related to
Sort By:
Page
of 27
Cancer Management and Research
|
December 29, 2010
Validation of the cell cycle G(2) delay assay in assessing ionizing radiation sensitivity and breast cancer risk
Jeff W Hill, Kristina Tansavatdi, Kristin L Lockett, et al.
Cancer
|
April 11, 2007
Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate
Thomas N Eade, Tahseen Al-Saleem, Eric M Horwitz, et al.
Cancer
|
October 31, 2007
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer
Matthew C Abramowitz, Tiaynu Li, Mark K Buyyounouski, et al.
Pharmaceutics
|
July 29, 2023
Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody-Gaussia Luciferase Fusion Protein
Jessica Hersh, Yu-Ping Yang, Evan Roberts, et al.
Journal of the American Animal Hospital Association
|
June 30, 2026
Intra-alveolar Adhesive Biomaterial Preserves Ridge Height After Tooth Extraction in Dogs
Christopher Snyder, Robert Baratt, Susan Crowder, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 25, 2010
Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?
Deborah A Kuban, Lawrence B Levy, M Rex Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 8, 2021
Prostate Cancer Targeted X-Ray Fluorescence Imaging via Gold Nanoparticles Functionalized With Prostate-Specific Membrane Antigen (PSMA)
Daiki Hara, Wensi Tao, Tulasigeri M Totiger, et al.
Journal of Applied Clinical Medical Physics
|
August 23, 2007
Comparing computed tomography localization with daily ultrasound during image-guided radiation therapy for the treatment of prostate cancer: a prospective evaluation
Steven J Feigenberg, Kamen Paskalev, Shawn McNeeley, et al.
The Prostate
|
January 16, 2008
Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo
Zhaomei Mu, Paul Hachem, Harvey Hensley, et al.
Cancer
|
March 26, 2003
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x
Alan Pollack, Didier Cowen, Patricia Troncoso, et al.
Page
of 27